Company Email Format Management

AffyImmune Therapeutics

Biotechnology Natick, Massachusetts, United States 12 employees

Employees: 12
Contacts: 2
Emails: 2
Phones: 2

affyimmune.com LinkedIn Crunchbase

AffyImmune Therapeutics Overview

Headquarters: Natick, Massachusetts, United States
Phone Number: Available in AeroLeads
Website: affyimmune.com
Industry: Biotechnology
Employees: 12
Founded: 2016
Funding: 20.0M

Keywords

oncology cart thyroidcancer gastriccancer celltherapy cgt

About AffyImmune Therapeutics

Founded in 2016, AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform. AIC100, our first product, spares healthy cells through our unique affinity-tuning, enhancing its safety and efficacy. The initial indication for AIC100 is refractory thyroid cancer, which has a very poor prognosis and very few effective therapies. The antigen targeted by AIC100 is also overexpressed in a variety of additional cancers, including stomach, triple negative breast cancer and a number of others.

AffyImmune Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

AffyImmune Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Daniel Janse	Chief Executive Officer at Affyimmune	Greater Boston, United States	Email Phone
Karrie Du, Pharm.d.	Biotechnology Cmc Professional - Cell		View
Gang Song	Chairman of the Board at Pillar	Newton Centre, Massachusetts, United States	Email Phone
Peter Gelinas	Accomplished Technical Operations		View